Inspiremd Share Price (NASDAQ: NSPR)

$2.43

▲

0.01

(0.41%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Inspiremd Stock chart to analyse performance

Inspiremd stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$2.41
Today's High:$2.43
$2.43
0.82%
Downside
Day's Volatility :0.82%
Upside
0.0%
52 Weeks Low:$1.99
52 Weeks High:$3.80
$2.43
18.11%
Downside
52 Weeks Volatility :47.6%
Upside
36.02%

Inspiremd Stock Returns

Period	Inspiremd Inc	Index (Russel 2000)
3 Months	-4.33%	0.0%
6 Months	-19.0%	0.0%
1 Year	-10.66%	0.0%
3 Years	41.28%	-4.7%

Inspiremd Inc Key Stats

Check Inspiremd key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$2.42
Open	$2.41
Today's High	$2.43
Today's Low	$2.41
Market Capitalization	$101.8M
Today's Volume	$32.6K
52 Week High	$3.798
52 Week Low	$1.99
Revenue TTM	$7.1M
EBITDA	$-42.0M
Earnings Per Share (EPS)	$-0.82
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-123.51%

Stock Returns calculator for Inspiremd Stock including INR - Dollar returns

The Inspiremd stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Inspiremd investment value today

Current value as on today

₹94,622

Returns

₹5,378

(-5.38%)

Returns from Inspiremd Stock

₹10,662 (-10.66%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Inspiremd Stock

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Inspiremd Stock from India on INDmoney has increased by 0% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Inspiremd Inc

Name
Holdings %
Name
Holdings %
Nantahala Capital Management, LLC
8.89%
Rosalind Advisors, Inc.
8.72%
Orbimed Advisors, LLC
8.18%
Soleus Capital Management, L.P.
7.23%
Marshall Wace Asset Management Ltd
7.13%
Parkman Healthcare Partners LLC
4.74%

Analyst Recommendation on Inspiremd Stock

Rating

Trend

Buy

85%Buy

14%Hold

0%Sell

Based on 7 Wall street analysts offering stock ratings for Inspiremd(by analysts ranked 0 to 5 stars)

Inspiremd Share Price Target

What analysts predicted

Upside of 85.19%

Target:

$4.50

Current:

$2.43

Inspiremd share price target is $4.50, a slight Upside of 85.19% compared to current price of $2.43 as per analysts' prediction.

Inspiremd Stock Insights

Price Movement
In the last 6 months, NSPR stock has moved down by -24.5%
Increasing Revenue
Revenue is up for the last 2 quarters, 1.52M → 1.77M (in $), with an average increase of 14.0% per quarter
Decreasing Net Profit
Netprofit is down for the last 4 quarters, -7.89M → -13.15M (in $), with an average decrease of 18.6% per quarter
NSPR vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 29.0% return, outperforming this stock by 40.6%
NSPR vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 163.5% return, outperforming this stock by 129.3%
Price to Sales
ForNSPR every $1 of sales, investors are willing to pay $17.1, whereas for Boston Scientific Corp., the investors are paying $8.4 for every $1 of sales.

Inspiremd Inc Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$3.7M	↑ 3.33%
Net Income	$-10.0M	↑ 38.67%
Net Profit Margin	-269.82%	↓ 68.76%

	FY20	Y/Y Change
Revenue	$2.5M	↓ 33.22%
Net Income	$-10.5M	↑ 5.02%
Net Profit Margin	-424.31%	↓ 154.49%

	FY21	Y/Y Change
Revenue	$4.5M	↑ 80.89%
Net Income	$-14.9M	↑ 41.48%
Net Profit Margin	-331.88%	↑ 92.43%

	FY22	Y/Y Change
Revenue	$5.2M	↑ 15.04%
Net Income	$-18.5M	↑ 23.95%
Net Profit Margin	-357.59%	↓ 25.71%

	FY23	Y/Y Change
Revenue	$6.2M	↑ 20.0%
Net Income	$-19.9M	↑ 7.71%
Net Profit Margin	-320.97%	↑ 36.62%

	FY24	Y/Y Change
Revenue	$7.0M	↑ 12.96%
Net Income	$-32.0M	↑ 60.7%
Net Profit Margin	-456.63%	↓ 135.66%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$1.5M	↓ 14.2%
Net Income	$-7.0M	↑ 30.1%
Net Profit Margin	-465.39%	↓ 158.46%

	Q2 FY24	Q/Q Change
Revenue	$1.7M	↑ 15.09%
Net Income	$-7.9M	↑ 12.47%
Net Profit Margin	-454.8%	↑ 10.59%

	Q3 FY24	Q/Q Change
Revenue	$1.8M	↑ 4.08%
Net Income	$-7.9M	↓ 0.24%
Net Profit Margin	-435.91%	↑ 18.89%

	Q4 FY24	Q/Q Change
Revenue	$1.9M	↑ 7.68%
Net Income	$-9.2M	↑ 16.27%
Net Profit Margin	-470.7%	↓ 34.79%

	Q1 FY25	Q/Q Change
Revenue	$1.5M	↓ 21.55%
Net Income	$-11.2M	↑ 21.71%
Net Profit Margin	-730.28%	↓ 259.58%

	Q2 FY25	Q/Q Change
Revenue	$1.8M	↑ 16.29%
Net Income	$-13.2M	↑ 17.78%
Net Profit Margin	-739.65%	↓ 9.37%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$756.0K	↓ 24.02%

	FY20	Y/Y Change
Profit	$83.0K	↓ 89.02%

	FY21	Y/Y Change
Profit	$754.0K	↑ 808.43%

	FY22	Y/Y Change
Profit	$1.1M	↑ 48.14%

	FY23	Y/Y Change
Profit	$1.8M	↑ 61.77%

	FY24	Y/Y Change
Profit	$1.5M	↓ 16.66%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$292.0K	↓ 42.18%

	Q2 FY24	Q/Q Change
Profit	$331.0K	↑ 13.36%

	Q3 FY24	Q/Q Change
Profit	$414.0K	↑ 25.08%

	Q4 FY24	Q/Q Change
Profit	$469.0K	↑ 13.29%

	Q1 FY25	Q/Q Change
Profit	$292.0K	↓ 37.74%

	Q2 FY25	Q/Q Change
Profit	$313.0K	↑ 7.19%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$-9.8M	↑ 28.98%
Investing Cash Flow	$-387.0K	↑ 779.55%
Financing Cash Flow	$6.3M	↓ 52.62%

	FY20	Y/Y Change
Operating Cash Flow	$-9.1M	↓ 7.43%
Investing Cash Flow	$-187.0K	↓ 51.68%
Financing Cash Flow	$16.4M	↑ 158.8%

	FY21	Y/Y Change
Operating Cash Flow	$-13.2M	↑ 45.47%
Investing Cash Flow	$-22.5M	↑ 11909.09%
Financing Cash Flow	$35.0M	↑ 113.69%

	FY22	Y/Y Change
Operating Cash Flow	$-15.5M	↑ 17.65%
Investing Cash Flow	$8.4M	↓ 137.59%
Financing Cash Flow	$-140.0K	↓ 100.4%

	FY23	Y/Y Change
Operating Cash Flow	$-16.4M	↑ 5.37%
Investing Cash Flow	$-16.1M	↓ 290.64%
Financing Cash Flow	$37.5M	↓ 26910.0%

	FY24	Y/Y Change
Operating Cash Flow	$-21.9M	↑ 33.54%
Investing Cash Flow	$12.6M	↓ 178.55%
Financing Cash Flow	$18.5M	↓ 50.84%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-5.1M	↑ 21.24%
Investing Cash Flow	$4.8M	↓ 13480.56%
Financing Cash Flow	$0.0	↓ 100.0%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$-4.4M	↓ 14.02%
Investing Cash Flow	$5.5M	↑ 14.3%
Financing Cash Flow	$17.9M	-

	Q3 FY24	Q/Q Change
Operating Cash Flow	$-5.7M	↑ 30.91%
Investing Cash Flow	$-5.9M	↓ 207.59%
Financing Cash Flow	$-965.0K	↓ 105.4%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$-6.8M	↑ 18.42%
Investing Cash Flow	$8.2M	↓ 239.13%
Financing Cash Flow	$1.6M	↓ 261.97%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$-8.8M	↑ 30.25%
Investing Cash Flow	$1.7M	↓ 79.35%
Financing Cash Flow	$506.0K	↓ 67.63%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$-8.3M	↓ 5.22%
Investing Cash Flow	$5.3M	↑ 212.69%
Financing Cash Flow	$2.1M	↑ 322.33%

Inspiremd Technicals Summary

Sell

Neutral

Buy

Inspiremd is currently in a neutral trading position according to technical analysis indicators.

Inspiremd Inc Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Inspiremd Inc	-9.67%	-19.0%	-10.66%	41.28%	-56.22%
Medtronic Plc	3.87%	-1.59%	4.32%	4.82%	-13.69%
Edwards Lifesciences Corp.	2.55%	13.95%	18.33%	-9.73%	-5.31%
Boston Scientific Corp.	0.09%	0.6%	30.02%	157.38%	154.4%
Stryker Corporation	3.63%	-0.85%	8.87%	89.43%	97.71%
Abbott Laboratories	5.15%	-5.37%	15.72%	26.56%	24.53%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Inspiremd Inc	NA	NA	0.0	-0.86	-1.24	-0.59	NA	0.62
Medtronic Plc	25.4	25.4	2.14	5.46	0.1	0.05	0.03	37.36
Edwards Lifesciences Corp.	34.03	34.03	4.85	2.5	0.16	0.08	NA	17.94
Boston Scientific Corp.	62.95	62.95	1.84	2.98	0.12	0.05	NA	15.14
Stryker Corporation	51.54	51.54	2.24	13.49	0.14	0.08	0.01	55.43
Abbott Laboratories	16.64	16.64	4.17	5.14	0.31	0.07	0.02	29.05

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Inspiremd Inc	Buy	$101.8M	-56.22%	NA	0.0%
Medtronic Plc	Buy	$118.0B	-13.69%	25.4	13.63%
Edwards Lifesciences Corp.	Buy	$47.8B	-5.31%	34.03	72.96%
Boston Scientific Corp.	Buy	$156.7B	154.4%	62.95	13.55%
Stryker Corporation	Buy	$149.0B	97.71%	51.54	12.25%
Abbott Laboratories	Buy	$230.9B	24.53%	16.64	32.43%

About Inspiremd Inc

InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery and other vascular diseases in Europe, Latin America, the Middle East, and the Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard neuroprotection system for transcarotid access and neuro protection, as well as treating acute stroke with tandem lesions. It has a strategic agreement with Jacobs Institute to execute an early feasibility study of CGuard Prime for the treatment of acute stroke patients with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Miami, Florida.

Organization	Inspiremd
Employees	66
CEO	Mr. Marvin L. Slosman
Industry	Health Technology

Key Management of Inspiremd Inc

Name	Title
Mr. Marvin L. Slosman	President, CEO & Director
Mr. Shane Thomas Gleason	Chief Commercial Officer
Mr. Michael A. Lawless	Chief Financial Officer
Mr. Andrea Tommasoli	Chief Operating Officer
Mr. Amir Kohen	Executive VP of Finance & Regional Manager
Mr. Pete J. Ligotti	Executive VP & GM of North America
Dr. Sol J. Barer Ph.D.	Special Advisor to the Board

Important FAQs about investing in NSPR Stock from India :

What is Inspiremd share price today?

Inspiremd share price today is $2.43 as on August 30, 2025 at 1:29 am IST at the close of the market. Inspiremd share today touched a day high of $2.43 and a low of $2.41.

What is the 52 week high and 52 week low for Inspiremd share?

Inspiremd share touched a 52 week high of $3.80 and a 52 week low of $1.99. Inspiremd stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $2.43, lower by 36.02% versus the 52 week high.

How to invest in Inspiremd Stock (NSPR) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Inspiremd on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Inspiremd Shares that will get you 0.6173 shares as per Inspiremd share price of $2.43 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Inspiremd Stock (NSPR) from India?

Indian investors can start investing in Inspiremd (NSPR) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Inspiremd stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Inspiremd share’s latest price of $2.43 as on August 30, 2025 at 1:29 am IST, you will get 4.1152 shares of Inspiremd. Learn more about fractional shares .

What are the returns that Inspiremd has given to Indian investors in the last 5 years?

Inspiremd stock has given -56.22% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?